Stock A065170 BL PHARMTECH CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials BL Pharmtech Corp.

Equities

A065170

KR7065170003

Food Processing

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
485 KRW -1.62% Intraday chart for BL Pharmtech Corp. +3.19% -3.96%
Mar. 28 Youngchul Park completed the acquisition of 24.43% stake in BL Pharmtech Corp. (KOSDAQ : A065170) from Bioleaders Corporation. CI
Mar. 20 BL Pharmtech Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 95,150 87,904 145,716 116,549 55,605 44,929
Enterprise Value (EV) 1 85,115 88,881 177,282 135,691 92,788 35,984
P/E ratio 66.8 x -7.42 x -6.92 x -5.69 x -4 x -302 x
Yield - - - - - -
Capitalization / Revenue 1.09 x 1.49 x 2.22 x 1.38 x 0.69 x 1.83 x
EV / Revenue 0.97 x 1.51 x 2.7 x 1.61 x 1.15 x 1.47 x
EV / EBITDA 19 x -13.7 x 378 x -925 x 183 x -5.74 x
EV / FCF -7.98 x -4.85 x -8.07 x 32.4 x -11.5 x 4.96 x
FCF Yield -12.5% -20.6% -12.4% 3.08% -8.72% 20.2%
Price to Book 1.59 x 1.93 x 2.2 x 1.99 x 1.65 x 1.43 x
Nbr of stocks (in thousands) 61,585 61,904 86,994 88,969 88,969 88,969
Reference price 2 1,545 1,420 1,675 1,310 625.0 505.0
Announcement Date 3/20/19 3/17/20 3/17/21 3/22/22 3/22/23 3/20/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 87,686 58,869 65,691 84,440 80,593 24,525
EBITDA 1 4,474 -6,497 469.5 -146.7 506.1 -6,271
EBIT 1 2,558 -8,087 -2,063 -3,595 -3,118 -7,119
Operating Margin 2.92% -13.74% -3.14% -4.26% -3.87% -29.03%
Earnings before Tax (EBT) 1 1,409 -16,597 -14,357 -20,570 -13,199 -13,856
Net income 1 1,302 -11,820 -17,947 -20,211 -13,903 -148.8
Net margin 1.48% -20.08% -27.32% -23.94% -17.25% -0.61%
EPS 2 23.12 -191.3 -242.1 -230.2 -156.3 -1.673
Free Cash Flow 1 -10,671 -18,341 -21,960 4,183 -8,087 7,260
FCF margin -12.17% -31.16% -33.43% 4.95% -10.03% 29.6%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/20/19 3/17/20 3/17/21 3/22/22 3/22/23 3/20/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 977 31,566 19,142 37,182 -
Net Cash position 1 10,034 - - - - 8,945
Leverage (Debt/EBITDA) - -0.1504 x 67.24 x -130.4 x 73.47 x -
Free Cash Flow 1 -10,671 -18,341 -21,960 4,183 -8,087 7,260
ROE (net income / shareholders' equity) 2.39% -28.4% -26.8% -29.1% -25.6% -37.9%
ROA (Net income/ Total Assets) 1.86% -5.24% -1.15% -1.7% -1.67% -5.99%
Assets 1 70,068 225,654 1,554,941 1,190,441 834,919 2,484
Book Value Per Share 2 973.0 734.0 760.0 657.0 380.0 353.0
Cash Flow per Share 2 515.0 367.0 142.0 244.0 56.50 119.0
Capex 1 4,421 23,464 17,626 587 1,708 312
Capex / Sales 5.04% 39.86% 26.83% 0.7% 2.12% 1.27%
Announcement Date 3/20/19 3/17/20 3/17/21 3/22/22 3/22/23 3/20/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
BL PHARMTECH CORP. Stock BL Pharmtech Corp.
-3.96% 31.35M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+8.20% 7.78B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+10.20% 6.52B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-8.10% 3.67B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-13.13% 3.44B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-14.57% 1.17B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+8.34% 934M
HERBALIFE LTD. Stock Herbalife Ltd.
-42.27% 879M
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-18.90% 836M
JAMIESON WELLNESS INC. Stock Jamieson Wellness Inc.
-16.45% 802M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. A065170 Stock
  4. Financials BL Pharmtech Corp.